| scholarly article | Q13442814 |
| P50 | author | Paul R. Hansen | Q54936624 |
| Peter Damborg | Q57207605 | ||
| Ines Greco | Q58826728 | ||
| Hanne Mørck Nielsen | Q44286889 | ||
| P2093 | author name string | Jeffrey L Watts | |
| Bernard D Hummel | |||
| Jason Koch | |||
| Jaspreet Vasir | |||
| Johannes E Hansen | |||
| P2860 | cites work | Absorption and disposition of a tripeptoid and a tetrapeptide in the rat | Q77333893 |
| Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37 | Q77630845 | ||
| Intranasal administration delivers peptoids to the rat central nervous system | Q81332263 | ||
| Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin | Q82282260 | ||
| Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). | Q38203577 | ||
| Strategic approaches to optimizing peptide ADME properties | Q38264736 | ||
| Peptide therapeutics: current status and future directions | Q38275750 | ||
| Antimicrobial stewardship in small animal veterinary practice: from theory to practice | Q38365676 | ||
| Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria | Q38726022 | ||
| Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs | Q40076286 | ||
| Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics | Q41869149 | ||
| Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. | Q41973626 | ||
| Lysine-Based α-Peptide/β-Peptoid Peptidomimetics: Influence of Hydrophobicity, Fluorination, and Distribution of Cationic Charge on Antimicrobial Activity and Cytotoxicity | Q42804043 | ||
| Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study | Q43116407 | ||
| Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). | Q44130492 | ||
| Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. | Q44899348 | ||
| Controlled release of vancomycin from poloxamer 407 gels. | Q44944078 | ||
| Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital | Q45087873 | ||
| Influence of skin penetration enhancers on skin barrier function and skin protease activity | Q46186642 | ||
| Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream | Q46260034 | ||
| Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. | Q46708620 | ||
| Antimicrobial Peptides: An Introduction | Q47375349 | ||
| β-Peptoids: synthesis of a novel dimer having a fully extended conformation | Q47975384 | ||
| Introduction: one health perspective | Q48737413 | ||
| Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective | Q22305939 | ||
| Novel formulations for antimicrobial peptides | Q26991771 | ||
| Antimicrobial peptides in 2014 | Q27027316 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| The 500 Dalton rule for the skin penetration of chemical compounds and drugs | Q28145766 | ||
| In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents | Q28553205 | ||
| Alternatives to antibiotics—a pipeline portfolio review | Q29365161 | ||
| A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes | Q30991281 | ||
| Peptoids: a modular approach to drug discovery. | Q33191665 | ||
| Potent antibacterial lysine-peptoid hybrids identified from a positional scanning combinatorial library | Q33235831 | ||
| Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides | Q33320587 | ||
| Peptoids as potential therapeutics. | Q33455976 | ||
| Antibiotic resistance--consequences for animal health, welfare, and food production | Q33667604 | ||
| Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index | Q34432501 | ||
| High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis | Q34478691 | ||
| Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides | Q35622159 | ||
| The effect of glycine replacement with flexible ω-amino acids on the antimicrobial and haemolytic activity of an amphipathic cyclic heptapeptide. | Q35759288 | ||
| In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids | Q36137272 | ||
| Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. | Q36337218 | ||
| A review of poloxamer 407 pharmaceutical and pharmacological characteristics. | Q36649745 | ||
| Periodate-triggered cross-linking reveals Sug2/Rpt4 as the molecular target of a peptoid inhibitor of the 19S proteasome regulatory particle | Q36893800 | ||
| Drug-metabolizing enzymes in the skin of man, rat, and pig. | Q37023993 | ||
| Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing. | Q37149078 | ||
| Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations | Q37194655 | ||
| Antimicrobial peptides: natural templates for synthetic membrane-active compounds. | Q37228452 | ||
| Structure-function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function | Q37431584 | ||
| Antimicrobial β-peptides and α-peptoids. | Q37832297 | ||
| Peptoids: bio-inspired polymers as potential pharmaceuticals | Q37897611 | ||
| Antimicrobial peptides: key components of the innate immune system | Q37954721 | ||
| Skin penetration enhancers | Q38086667 | ||
| Peptides as the next generation of anti-infectives. | Q38086871 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2018-03-10 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | In Vitro ADME Properties of Two Novel Antimicrobial Peptoid-Based Compounds as Potential Agents against Canine Pyoderma. | |
| P478 | volume | 23 |
| Q63761617 | Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections |
| Q90309111 | In Vitro Efficiency of Antimicrobial Peptides against Staphylococcal Pathogens Associated with Canine Pyoderma |
| Q89422369 | Self-Assembled Antimicrobial Nanomaterials |
| Q92048975 | Structure-Activity Study of an All-d Antimicrobial Octapeptide D2D |
| Q63761615 | Structure⁻Activity Study, Characterization, and Mechanism of Action of an Antimicrobial Peptoid D2 and Its d- and l-Peptide Analogues |
Search more.